5 DMD Data Readouts to Watch in 2024
Pictured: A boy in a wheelchair over a muscle texture background/Taylor Tieden for BioSpace The March approval of ITF Therapeutics’ Duvyzat marked the third new FDA-approved treatment in 10 months for Duchenne muscular dystrophy (DMD), a genetic …